NTHI Projected Dividend Yield

NeOnc Technologies Holdings Inc ( NASDAQ : NTHI )

NeOnc Technologies Holdings is a clinical-stage life sciences company engaged on the development and commercialization of central nervous system therapeutics designed to address the persistent challenges of overcoming the blood-brain barrier. Co. is engaged in the research and development of therapies for the treatment of central nervous system disorders. NeOnc has two lead products: NEO100 and NEO212. NEO100 is a purified form of perillyl acid, administered to brain cancer patients via intranasal delivery. Additionally, NEO212 is a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol.

21 YEAR PERFORMANCE RESULTS

NTHI Dividend History Detail
NTHI Dividend News
NTHI Competitors News
# of Shares: 0 Closing Price: 5.95 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2014 0.00 0% 0 $ 0.00 0.00%
2015 0.00 0% 0 $ 0.00 0.00%
2016 0.00 0% 0 $ 0.00 0.00%
2017 0.00 0% 0 $ 0.00 0.00%
2018 0.00 0% 0 $ 0.00 0.00%
2019 0.00 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.00 0% 0 $ 0.00 0.00%
2022 0.00 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.00 0% 0 $ 0.00 0.00%
2025 0.00 0% 0 $ 0.00 0.00%
2026 0.00 0% 0 $ 0.00 0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
Total:
0.0000
X
Search Dividend Investor